Altered flow-mediated vasodilatation, low paraoxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis

Circulation Journal

Volumn 73, Issue 4, 2009, Pages 760-766

  Espinola Zavaleta, Nilda ^a   Soto López, María Elena ^a   Carreón Torres, Elizabeth ^a   Gamboa, Ricardo ^a   Mejía, Ana M ^a   Márquez Velasco, Ricardo ^a   Bojalil, Rafael ^a   Huesca Gomez, Claudia ^a   Reyes, Pedro A ^a   Pérez Méndez, Oscar ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Endothelial dysfunction; High density lipoprotein subclasses; Paraoxonase 1; Takayasu's arteritis; Vasculitis

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARYLDIALKYLPHOSPHATASE 1; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHENYLACETIC ACID; PREDNISONE;

ADULT; AORTA ARCH SYNDROME; ARTICLE; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN LOCALIZATION; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ADULT; ARYLDIALKYLPHOSPHATASE; BLOOD FLOW VELOCITY; FEMALE; HUMANS; LIPOPROTEINS, HDL3; MIDDLE AGED; TAKAYASU ARTERITIS; VASODILATION;

EID: 65649129641     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-0582     Document Type: Article

References (44)

1. Numano F. Introductory remarks for this special issue on Takayasu arteritis. Heart Vessels Suppl 1992; 7: 3-5.
2. Numano F. Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 2000; 75: S1-S8.
3. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric-oxide pathway in offspring of essential hypertensive patients. Circulation 1996; 94: 1298-1303. (Pubitemid 26307256)
4. Park JB, Charbonneau F, Schiffrin EL. Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens 2001; 19: 415-420. (Pubitemid 32195377)
5. Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, et al. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation 2001; 103: 1238-1244. (Pubitemid 32221346)
6. Schofield I, Malik R, Izzard A, Austin C, Heagerty A. Vascular structural and functional changes in Type 2 diabetes mellitus: Evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002; 106: 3037-3043. (Pubitemid 35440285)
7. Kirma C, Akcakoyun M, Esen AM, Barutcu I, Karakaya O, Saglam M, et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J 2007; 71: 698-702. (Pubitemid 46683360)
8. Monnink SH, van Haelst PL, Van Boven AJ, Stroes ES, Tio RA, Plokker TW, et al. Endothelial dysfunction in patients with coronary artery disease: A comparison of three frequently reported tests. J Invest Med 2002; 50: 19-24. (Pubitemid 34098284)
9. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xantine-oxidase and extracellular superoxide dismutase. Circulation 2002; 106: 3073-3078. (Pubitemid 35440291)
10. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000; 101: 1780-1784. (Pubitemid 30213098)
11. Bolton CH, Downs LG, Victory JG, Dwight JF, Tomson CR, Mackness MI, et al. Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 12: 1189-1197. (Pubitemid 32547374)
12. Quyyumi AA. Prognostic value of endothelial function. Am J Cardiol 2003; 91: 19H-24H. (Pubitemid 36724891)
13. Soga J, Nishioka K, Nakamura S, Umemura T, Jitsuiki D, Hidaka T, et al. Measurement of flow-mediated vasodilation of the brachial artery: A comparison of measurements in the seated and supine positions. Circ J 2007; 71: 736-740 (Pubitemid 46683366)
14. Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk: The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124: S11-S20. (Pubitemid 26268441)
15. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847. (Pubitemid 28213628)
16. Bloomfield-Rubins H, Davenport J, Babikian V, Brass LM, Collins D, Wexler L, et al. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 2001; 103: 2828-2833. (Pubitemid 32550072)
17. Sviridov D, Nestel P. Dynamics of reverse cholesterol transport: Protection against atherosclerosis. Atherosclerosis 2002; 161: 245-254. (Pubitemid 34219176)
18. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006; 98: 1352-1364. (Pubitemid 43948059)
19. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581-1590. (Pubitemid 28198486)
20. Deakin S, Leviev I, Gomaraschi M, Calabresi L, Franceschini G, James RW. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem 2002; 277: 4301-4308.
21. Kontush A, Chantepie S, Chapman MJ. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003; 23: 1881-1888. (Pubitemid 37254879)
22. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-1134. (Pubitemid 20273298)
23. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: New classification. Int J Cardiol 1996; 54(Suppl): S155-S163.
24. Gan KL, Smolen A, Eckerson HW, La Du BN. Protein purification of human serum paraoxonase/arylesterase: Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991; 19: 100-106.
25. Huesca-Gómez C, Franco M, Luc G, Montano LF, Masso F, Posadas-Romero C, et al. Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat. Metabolism 2002; 51: 443-450. (Pubitemid 34406559)
26. Huesca-Gómez C, Carreon-Torres E, Nepomuceno-Mejía T, Sanchez-Solorio M, Galicia-Hidalgo M, Mejia AM, et al. Contribution of cholesterol ester transfer protein and lecithin: Cholesterol acyl transferase to HDL size distribution. Endocr Res 2004; 30: 403-415. (Pubitemid 39453088)
27. Krishnan R, Becker RJ, Beighley LM, Lopez-Candales A. Impact of body mass index on markers of left ventricular thickness and mass calculation: Results of a pilot analysis. Echocardiography 2005; 22: 203-210. (Pubitemid 40344412)
28. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002; 39: 257-265.
29. Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E. Clinical applications of noninvasive vascular ultrasound in cardiovascular risk stratification: A report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006; 19: 943-954. (Pubitemid 44118704)
30. Higashi Y, Sasaki S, Kurisu S, Yoshimizu A, Sasaki N, Matsuura H, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: Role of endothelium-derived nitric oxide. Circulation 1999; 100: 1194-1202. (Pubitemid 29426595)
31. Joannides R, Bellien J, Thurlure C, Iacob M, Abeel M, Thuillez C. Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration. Am J Hypertens 2008; 21: 679-684.
32. Hafström I, Rohani M, Deneberg S, Wörnert M, Jogestrand T, Frostegård J. Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis: A randomized study. J Rheumatol 2007; 34: 1810-1816. (Pubitemid 350067638)
33. Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology 2006; 45: 545-548.
34. Erzen B, Gradisek P, Poredos P, Sabovic M. Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries. Angiology 2006; 57: 187-192. (Pubitemid 44438570)
35. Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002; 29: 292-297. (Pubitemid 34118776)
36. Protogerou AD, Sfikakis PP, Stamatelopoulos KS, Papamichael C, Aznaouridis K, Karatzis E, et al. Interrelated modulation of endothelial function in Behcet's disease by clinical activity and corticosteroid treatment. Arthritis Res Ther 2007; 9: R90. (Pubitemid 350020814)
37. Pasqualini L, Cortese C, Marchesi S, Siepi D, Pirro M, Vaudo G, et al. Paraoxonase-1 activity modulates endothelium function in patients with peripheral arterial disease. Atherosclerosis 2005; 183: 349-354. (Pubitemid 41579288)
38. Keynes RG, Griffiths CH, Hall C, Garthwaite J. Nitric oxide consumption through lipid peroxidation in brain cell suspensions and homogenates. Biochem J 2005; 387: 685-694. (Pubitemid 40685702)
39. Uzun H, Karter Y, Aydin S, Curgulu A, Simsek G, Yucel R, et al. Oxidative stress in white coat hypertension, role of paraoxonase. J Hypertens 2004; 18: 523-528. (Pubitemid 39023200)
40. Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, et al. Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 1998; 9: 2082-2088. (Pubitemid 28482156)
41. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 1995; 15: 1812-1818.
42. Schillaci G, Vaudo G, Reboldi G, Verdecchia P, Lupattelli G, Pasqualini L, et al. High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension. J Hypertens 2001; 19: 2265-2270. (Pubitemid 33135250)
43. Anan F, Yonemochi H, Masaki T, Takahashi N, Fukunaga N, Teshima Y, et al. High-density lipoprotein cholesterol and insulin resistance are independent and additive markers of left ventricular hypertrophy in essential hypertension. Hypertens Res 2007; 30: 125-131. (Pubitemid 46541786)
44. Pérez-Méndez O, Torres-Tamayo M, Posadas-Romero C, Vidaure Garcés V, Carreón-Torres E, Mendoza-Pérez E, et al. Abnormal HDL subclasses distribution in overweight children with insulin resistance or type 2 diabetes mellitus. Clin Chim Acta 2007; 376: 17-22.